Theophylline
 OpenBabel02212023462D

 13 14  0  0  0  0  0  0  0  0999 V2000
    0.7145   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7145   -0.4125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0000   -0.0000    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.0000    0.8250    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.7846    1.0799    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2695    0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7846   -0.2549    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7145    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7145    2.0625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4289    0.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1434    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4289    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1434   -0.4125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2 12  1  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4  5  1  0  0  0  0
  4  8  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  8  9  2  0  0  0  0
  8 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 12  1  0  0  0  0
 12 13  2  0  0  0  0
M  END
>  <CdId>
625

>  <Mol Weight>
180.164

>  <Formula>
C7H8N4O2

>  <ID>
T1083

>  <Name>
Theophylline

>  <Synonyms>
1,3-Dimethylxanthine;Theo-24

>  <CAS>
58-55-9

>  <Approved status>
FDA

>  <Disease>
Respiratory system

>  <Indication>
Asthma; Chronic Obstructive Pulmonary Disease

>  <Pathways>
Chromatin/Epigenetic; Metabolism; Neuroscience; DNA Damage/DNA Repair; NF-¦ªb

>  <Target>
AChR antagonist; HDAC activator; PDE inhibitor

>  <Receptor>
Adenosine receptor; HDAC2; PDE

$$$$
